We are live on ! Find out more
LUCD icon

Lucid Diagnostics

34 hedge funds and large institutions have $1.64M invested in Lucid Diagnostics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

13% more funds holding

Funds holding: 3034 (+4)

0.49% less ownership

Funds ownership: 4.29%3.8% (-0.49%)

3% less capital invested

Capital invested by funds: $1.69M → $1.64M (-$52.2K)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
8
Reduced
9
Closed
4
Calls
Puts
Net Calls
Net Calls Change

LUCD Hedge Fund Activity: Q2 2024 in Review

34 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q2 2024, worth a combined $1.64M — down 3.1% from $1.69M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new LUCD positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Lido Advisors, opening a new position worth an estimated $57.7K. The largest seller was Jane Street, exiting entirely with an estimated $98.8K sold.

  • 34 institutional investors held Lucid Diagnostics (LUCD) as of Q2 2024, up from 30 in Q1 2024.
  • Funds reported $1.64M of Lucid Diagnostics stock for Q2 2024, down 3.1% quarter-over-quarter.
  • 8 funds opened new Lucid Diagnostics positions in Q2 2024 and 4 closed out, a net change of +4 holders.
  • The largest Lucid Diagnostics buyer in Q2 2024 was Lido Advisors, an estimated $57.7K added.
  • The largest Lucid Diagnostics seller in Q2 2024 was Jane Street, an estimated $98.8K sold.

Based on aggregated 13F filings for Q2 2024.